Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02043496 · ClinicalTrials.gov registry record · NA
Integrative Cognitive-Affective Therapy for Binge Eating Disorder
A NA study of Binge-Eating Disorder, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 2
- Study locations
NCT02043496: Completed NA study of Binge-Eating Disorder, sponsored by University of Minnesota.
NCT02043496 is a NA study of Binge-Eating Disorder that has completed, run by University of Minnesota. The registered enrollment target is 96 participants, below the 1,141-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02043496, a NA study of Binge-Eating Disorder, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to test a newly developed individual psychotherapy treatment for binge eating disorder in adults. This treatment is a type of individual psychotherapy called Integrative Cognitive-Affective Therapy (ICAT) that focuses on helping people change their behaviors, feelings, thoughts about themselves, and relationships. This new treatment is being compared to an existing treatment called Cognitive-Behavior Therapy-Guided Self Help (CBTgsh), which focuses on changing behavior patterns through the use of reading and homework assignments along with sessions with a therapist. The primary hypothesis of this investigation is that ICAT will be associated with greater reductions in binge eating at end of treatment and follow-up compared to CBTgsh.
Primary Outcome
Frequency of binge eating as measured by the Eating Disorder Examination
Conditions Studied
Interventions
- BEHAVIORAL Integrative Cognitive-Affective Therapy
- BEHAVIORAL CBT-Guided Self Help
Study Locations (2)
Minnesota
- University of Minnesota - Minneapolis
North Dakota
- Neuropsychiatric Research Institute - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02043496 record still lists
NCT02043496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,141-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 2 interventions - of which Integrative Cognitive-Affective Therapy is the first listed.
NCT02043496 reports a single indexed study location in Minnesota, North Dakota.
Frequently Asked Questions
What is clinical trial NCT02043496 about?
NCT02043496 is a clinical study titled "Integrative Cognitive-Affective Therapy for Binge Eating Disorder". The purpose of the study is to test a newly developed individual psychotherapy treatment for binge eating disorder in adults. This treatment is a type of individual psychotherapy called Integrative Cognitive-Affective Therapy (ICAT) that focuses on helping people change their behaviors, feelings, th...
What is the current status of trial NCT02043496?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2013-12. Estimated completion is 2017-08.
What conditions does trial NCT02043496 study?
This clinical trial studies the following conditions: Binge-Eating Disorder.
What interventions are being tested in trial NCT02043496?
The interventions under investigation include: Integrative Cognitive-Affective Therapy (BEHAVIORAL), CBT-Guided Self Help (BEHAVIORAL).
Who is sponsoring clinical trial NCT02043496?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02043496 being conducted?
This trial has 2 study locations across Minnesota, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02043496's enrollment target sits among peer trials
96 16th of 37 higher than 21 of 37 other Binge-Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia